Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Observation × Myeloid × Clear all

Status

Completed 2 Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 21 Thoracic 8 Gynecologic 6 Breast 6 Lymphoid 5 Head & Neck 5 Genitourinary 5 Sarcoma 4 Dermatologic 4 CNS 4 Tumor-Agnostic 3 Other hematologic neoplasm 3 Other solid neoplasm 2 Other 2 Plasma cell 1 Myeloid 1 Endocrine 1

Conditions

Childhood Myeloproliferative Neoplasms 1

Interventions

venetoclax 33 fludarabine 32 Azacitidine 30 Cyclophosphamide 29 Specimen Handling 27 Biopsy 21 Cytarabine 18 fludarabine phosphate 16 ruxolitinib 15 Whole-Body Irradiation 15 Decitabine 15 Stem Cell Transplantation 14 Tacrolimus 13 Melphalan 13 Mycophenolic Acid 11 Injections 11 Busulfan 11 decitabine and cedazuridine drug combination 9 asciminib 9 Thiotepa 8 Methotrexate 8 Granulocyte Colony-Stimulating Factor 8 X-Rays 7 Hematopoietic Stem Cell Transplantation 7 Magnetic Resonance Spectroscopy 6 Idarubicin 6 Filgrastim 6 tagraxofusp 5 nilotinib 5 gilteritinib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07410247 2026-02-13

MPN Childhood Registry

University of Erlangen-Nürnberg Medical School

Childhood Myeloproliferative Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡